Literature DB >> 20950954

Patient selection and activity planning guide for selective internal radiotherapy with yttrium-90 resin microspheres.

Wan-Yee Lau1, Andrew S Kennedy, Yun Hwan Kim, Hee Kit Lai, Rheun-Chuan Lee, Thomas W T Leung, Ching-Sheng Liu, Riad Salem, Bruno Sangro, Borys Shuter, Shih-Chang Wang.   

Abstract

PURPOSE: Selective internal radiotherapy (SIRT) with yttrium-90 ((90)Y) resin microspheres can improve the clinical outcomes for selected patients with inoperable liver cancer. This technique involves intra-arterial delivery of β-emitting microspheres into hepatocellular carcinomas or liver metastases while sparing uninvolved structures. Its unique mode of action, including both (90)Y brachytherapy and embolization of neoplastic microvasculature, necessitates activity planning methods specific to SIRT. METHODS AND MATERIALS: A panel of clinicians experienced in (90)Y resin microsphere SIRT was convened to integrate clinical experience with the published data to propose an activity planning pathway for radioembolization.
RESULTS: Accurate planning is essential to minimize potentially fatal sequelae such as radiation-induced liver disease while delivering tumoricidal (90)Y activity. Planning methods have included empiric dosing according to degree of tumor involvement, empiric dosing adjusted for the body surface area, and partition model calculations using Medical Internal Radiation Dose principles. It has been recommended that at least two of these methods be compared when calculating the microsphere activity for each patient.
CONCLUSIONS: Many factors inform (90)Y resin microsphere SIRT activity planning, including the therapeutic intent, tissue and vasculature imaging, tumor and uninvolved liver characteristics, previous therapies, and localization of the microsphere infusion. The influence of each of these factors has been discussed.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20950954     DOI: 10.1016/j.ijrobp.2010.08.015

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  49 in total

1.  Surgical resection versus conformal radiotherapy combined with TACE for resectable hepatocellular carcinoma with portal vein tumor thrombus: a comparative study: reply.

Authors:  W Y Lau; W P Zhou
Journal:  World J Surg       Date:  2014-05       Impact factor: 3.352

Review 2.  Radioembolization of hepatic tumors.

Authors:  Andrew Kennedy
Journal:  J Gastrointest Oncol       Date:  2014-06

3.  Radioembolization with (90)Y-loaded microspheres: high clinical impact of treatment simulation with MAA-based dosimetry.

Authors:  Etienne Garin
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-07       Impact factor: 9.236

Review 4.  Yttrium-90 Radioembolization Dosimetry: What Trainees Need to Know.

Authors:  Alexander Villalobos; Mohamed M Soliman; Bill S Majdalany; David M Schuster; James Galt; Zachary L Bercu; Nima Kokabi
Journal:  Semin Intervent Radiol       Date:  2020-12-11       Impact factor: 1.513

5.  The dosimetric importance of the number of 90Y microspheres in liver transarterial radioembolization (TARE).

Authors:  Carlo Spreafico; Marco Maccauro; Vincenzo Mazzaferro; Carlo Chiesa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-04       Impact factor: 9.236

6.  (⁹⁹m)Tc-MAA overestimates the absorbed dose to the lungs in radioembolization: a quantitative evaluation in patients treated with ¹⁶⁶Ho-microspheres.

Authors:  Mattijs Elschot; Johannes F W Nijsen; Marnix G E H Lam; Maarten L J Smits; Jip F Prince; Max A Viergever; Maurice A A J van den Bosch; Bernard A Zonnenberg; Hugo W A M de Jong
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-05-13       Impact factor: 9.236

Review 7.  Yttrium-90 hepatic radioembolization: clinical review and current techniques in interventional radiology and personalized dosimetry.

Authors:  Aaron K T Tong; Yung Hsiang Kao; Chow Wei Too; Kenneth F W Chin; David C E Ng; Pierce K H Chow
Journal:  Br J Radiol       Date:  2016-03-24       Impact factor: 3.039

8.  166Ho microsphere scout dose for more accurate radioembolization treatment planning.

Authors:  C Chiesa; M Maccauro
Journal:  Eur J Nucl Med Mol Imaging       Date:  2020-04       Impact factor: 9.236

9.  Perfusion CT best predicts outcome after radioembolization of liver metastases: a comparison of radionuclide and CT imaging techniques.

Authors:  Fabian Morsbach; Bert-Ram Sah; Lea Spring; Gilbert Puippe; Sonja Gordic; Burkhardt Seifert; Niklaus Schaefer; Thomas Pfammatter; Hatem Alkadhi; Caecilia S Reiner
Journal:  Eur Radiol       Date:  2014-05-12       Impact factor: 5.315

10.  A review of 3D image-based dosimetry, technical considerations and emerging perspectives in 90Y microsphere therapy.

Authors:  Jim O' Doherty
Journal:  J Diagn Imaging Ther       Date:  2015-04-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.